1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term incidence of venous thromboembolism (VTE) among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Madenci, A. L.; Weil, B.; Liu, Q.; Gibson, T. M.; Yasui, Y.; Leisenring, W. M.; Howell, R. M.; Tinkle, C.; Nekhlyudov, L.; Diller, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Patient centered outcomes for skin cancer treatment: A single day Delphi process to assess the importance of treatment themes to a representative panel of skin cancer patients
    Meeting Abstract

    Maher, I.; Alam, M.; Bordeaux, J. S.; Cartee, T.; Baum, C.; Rossi, A.; Lawrence, N.; Behera, A.; Armbrecht, E. S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Association of delayed adjuvant therapy and overall survival in early stage endometrial cancer
    Meeting Abstract

    Luo, L.; Shi, W.; Zhang, Z.; Tsai, C. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times
    Meeting Abstract

    Losk, K.; Freedman, R. A.; Lin, N. U.; Golshan, M.; Lester, S.; Pochebit, S.; Natsuhara, K.; Camuso, K.; King, T. A.; Bunnell, C. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)
    Meeting Abstract

    Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation
    Meeting Abstract

    Lowery, M. A.; Abou-Alfa, G. K.; Valle, J. W.; Kelley, R. K.; Goyal, L.; Shroff, R. T.; Javle, M. M.; Borad, M. J.; Cleary, J. M.; El-Khoueiry, A. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • First-in-class oral ERK1/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: Final results of a phase I dose escalation and expansion study
    Meeting Abstract

    Li, B. T.; Janku, F.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Buchbinder, E. I.; Lacouture, M. E.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders
    Meeting Abstract

    Leonardi, G. C.; Gainor, J. F.; Azimi, R. S.; Riess, J.; Rizvi, H.; Hellmann, M. D.; Awad, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Liu, D.; Horiates, K.; Mathew, S.; Pozotrigo, M.; Thackray, J.; Kussin, M.; Yan, S. Q.; Seyboth, B. M.; Modak, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save